$CAH
CARDINAL HEALTH INC Stock $cah

$cah Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000072137118000020 Filed on February 08, 2018

Income Statement

Concept	2017 Q4	2016 Q4	2016 Q2
Revenue	$35.19B	$33.15B	$31.38B
YoY Change	6.14%	5.42%	13.93%
Cost Of Revenue	$33.33B	$31.55B	$29.72B
YoY Change	5.63%	5.74%	13.91%
Gross Profit	$1.861B	$1.602B	$1.665B
YoY Change	16.17%	-0.44%	14.2%
Gross Profit Margin	5.29%	4.83%	5.31%
Selling, General & Admin	$1.131B	$910.0M	$970.0M
YoY Change	24.29%	-1.3%	14.52%
% of Gross Profit	60.77%	56.8%	58.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$291.0M	$166.0M	$176.0M
YoY Change	75.3%	-1.78%	53.04%
% of Gross Profit	15.64%	10.36%	10.57%
Operating Expenses	$1.131B	$910.0M	$970.0M
YoY Change	24.29%	-1.3%	14.52%
Operating Profit	$399.0M	$542.0M	$695.0M
YoY Change	-26.38%	-3.73%	13.75%
Interest Expense	$87.00M	$44.00M	-$44.00M
YoY Change	97.73%	-2.22%	22.22%
% of Operating Profit	21.8%	8.12%	-6.33%
Other Income/Expense, Net	$5.000M	-$7.000M	$0.00
YoY Change	-171.43%	-450.0%	-100.0%
Pretax Income	$317.0M	$491.0M	$576.0M
YoY Change	-35.44%	-5.58%	10.13%
Income Tax	-$736.0M	$167.0M	$241.0M
% Of Pretax Income	-232.18%	34.01%	41.84%
Net Earnings	$1.053B	$324.0M	$333.0M
YoY Change	225.0%	-0.61%	12.88%
Net Earnings / Revenue	2.99%	0.98%	1.06%
Basic Earnings Per Share
Diluted Earnings Per Share	$3.332M	$1.016M	$1.015M
COMMON SHARES
Basic Shares Outstanding	315.0M shares	318.0M shares	325.8M shares
Diluted Shares Outstanding	316.0M shares	319.0M shares

Balance Sheet

Concept	2017 Q4	2016 Q4	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.249B	$1.881B	$2.356B
YoY Change	-33.6%	-19.06%	-48.96%
Cash & Equivalents	$1.249B	$1.881B	$2.356B
Short-Term Investments
Other Short-Term Assets	$1.972B	$1.824B	$1.580B
YoY Change	8.11%	20.16%	12.7%
Inventory	$12.09B	$11.92B	$10.62B
Prepaid Expenses
Receivables	$7.664B	$7.533B	$7.405B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$25.19B	$23.15B	$21.96B
YoY Change	8.79%	6.07%	0.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.547B	$1.856B	$1.796B
YoY Change	37.23%	12.42%	19.26%
Goodwill	$10.05B	$7.212B	$7.167B
YoY Change	39.28%	6.07%	41.36%
Intangibles	$4.321B	$2.064B	$1.986B
YoY Change	109.35%	-10.8%	109.49%
Long-Term Investments
YoY Change
Other Assets	$804.0M	$736.0M	$944.0M
YoY Change	9.24%	-19.47%	9.01%
Total Long-Term Assets	$17.72B	$11.87B	$12.17B
YoY Change	49.28%	1.63%	45.01%
TOTAL ASSETS
Total Short-Term Assets	$25.19B	$23.15B	$21.96B
Total Long-Term Assets	$17.72B	$11.87B	$12.17B
Total Assets	$42.91B	$35.02B	$34.12B
YoY Change	22.51%	4.52%	13.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.19B	$18.86B	$17.31B
YoY Change	1.79%	11.45%	20.45%
Accrued Expenses	$1.890B	$1.554B	$1.808B
YoY Change	21.62%	-3.24%	-30.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$702.0M	$603.0M	$587.0M
YoY Change	16.42%	70.34%	108.9%
Total Short-Term Liabilities	$23.13B	$21.01B	$19.70B
YoY Change	10.05%	11.31%	14.26%
LONG-TERM LIABILITIES
Long-Term Debt	$9.057B	$4.859B	$4.952B
YoY Change	86.4%	-6.03%	-4.97%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$9.057B	$4.859B	$4.952B
YoY Change	86.4%	-6.03%	-4.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.13B	$21.01B	$19.70B
Total Long-Term Liabilities	$9.057B	$4.859B	$4.952B
Total Liabilities	$35.31B	$28.70B	$27.57B
YoY Change	23.03%	7.1%	15.41%
SHAREHOLDERS EQUITY
Retained Earnings	$5.848B	$4.604B	$6.419B
YoY Change	27.02%	-22.91%	16.27%
Common Stock	$2.694B	$2.672B	$3.010B
YoY Change	0.82%	-10.12%	0.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$848.0M	$783.0M	$2.759B
YoY Change	8.3%	-63.36%	22.9%
Treasury Stock Shares		11.00M shares	42.00M shares
Shareholders Equity	$7.599B	$6.323B	$6.554B
YoY Change
Total Liabilities & Shareholders Equity	$42.91B	$35.02B	$34.12B
YoY Change	22.51%	4.52%	13.2%

Cashflow Statement

Concept	2017 Q4	2016 Q4	2016 Q2
OPERATING ACTIVITIES
Net Income	$1.053B	$324.0M	$333.0M
YoY Change	225.0%	-0.61%	12.88%
Depreciation, Depletion And Amortization	$291.0M	$166.0M	$176.0M
YoY Change	75.3%	-1.78%	53.04%
Cash From Operating Activities	$261.0M	$554.0M	$641.0M
YoY Change	-52.89%	-62.13%	-26.15%
INVESTING ACTIVITIES
Capital Expenditures	-$101.0M	-$113.0M	-$181.0M
YoY Change	-10.62%	22.83%	12.42%
Acquisitions
YoY Change
Other Investing Activities	-$4.000M	-$14.00M	-$218.0M
YoY Change	-71.43%	-99.26%	-27.81%
Cash From Investing Activities	-$105.0M	-$127.0M	-$399.0M
YoY Change	-17.32%	-93.63%	-13.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-86.00M	-536.0M	-479.0M
YoY Change	-83.96%	387.27%	-146.6%
NET CHANGE
Cash From Operating Activities	261.0M	554.0M	641.0M
Cash From Investing Activities	-105.0M	-127.0M	-399.0M
Cash From Financing Activities	-86.00M	-536.0M	-479.0M
Net Change In Cash	70.00M	-109.0M	-237.0M
YoY Change	-164.22%	-82.97%	-116.54%
FREE CASH FLOW
Cash From Operating Activities	$261.0M	$554.0M	$641.0M
Capital Expenditures	-$101.0M	-$113.0M	-$181.0M
Free Cash Flow	$362.0M	$667.0M	$822.0M
YoY Change	-45.73%	-57.11%	-20.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3000000	shares
CY2016Q4	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	115000000	USD
	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	237000000	USD
CY2017Q4	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	184000000	USD
	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	368000000	USD
CY2017Q4	cah	Cash Paid For Contract Termination CashPaidForContractTermination	65000000	USD
	cah	Cash Reclassifiedto Assets Heldfor Sale CashReclassifiedtoAssetsHeldforSale	0	USD
	cah	Cash Reclassifiedto Assets Heldfor Sale CashReclassifiedtoAssetsHeldforSale	-18000000	USD
CY2017Q4	cah	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Transition Taxon Accumulated Foreign Earnings Amount EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount	41000000	USD
CY2016Q4	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	1000000	USD
	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	3000000	USD
CY2017Q4	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	6000000	USD
	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	134000000	USD
	cah	Increase Decrease In Dollar Amount Of Common Sharesin Treasury From Retirement Of Shares IncreaseDecreaseInDollarAmountOfCommonSharesinTreasuryFromRetirementOfShares	-2500000000	USD
	cah	Increase Decrease In Retained Earnings From Retirement Of Shares IncreaseDecreaseInRetainedEarningsFromRetirementOfShares	-2200000000	USD
	cah	Increase Decreasein Common Shares Amount From Retirementof Shares IncreaseDecreaseinCommonSharesAmountFromRetirementofShares	-302000000	USD
CY2017Q2	cah	Indemnification Receivable IndemnificationReceivable	142000000	USD
CY2017Q4	cah	Indemnification Receivable IndemnificationReceivable	146000000	USD
CY2017Q4	cah	Loss Contingency Accrual Netof Insurance Recoveries LossContingencyAccrualNetofInsuranceRecoveries	184000000	USD
	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	0	USD
	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	-16000000	USD
CY2017Q4	cah	Other Intangible Assets Reclassifiedto Assets Heldfor Sales OtherIntangibleAssetsReclassifiedtoAssetsHeldforSales	61000000	USD
	cah	Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets	1000000	USD
	cah	Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets	1000000	USD
	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	72000000	USD
	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	65000000	USD
CY2016Q4	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	1000000	USD
	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	2000000	USD
CY2017Q4	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	6000000	USD
	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	11000000	USD
	cah	Purchaseofavailableforsalesecuritiesandotherinvestments Purchaseofavailableforsalesecuritiesandotherinvestments	125000000	USD
	cah	Purchaseofavailableforsalesecuritiesandotherinvestments Purchaseofavailableforsalesecuritiesandotherinvestments	6000000	USD
	cah	Reclassifiedtoassetsheldforsale Reclassifiedtoassetsheldforsale	-387000000	USD
CY2017Q4	cah	Tax Cutsand Jobs Actof2017 Changein Tax Rate Deferred Tax Asset Income Tax Expense Benefit TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxAssetIncomeTaxExpenseBenefit	-935000000	USD
CY2017Q4	cah	Tax Cutsand Jobs Actof2017 Measurement Period Adjustment Income Tax Expense Benefit TaxCutsandJobsActof2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit	-935000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000721371
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	314706914	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CARDINAL HEALTH INC
	dei	Trading Symbol TradingSymbol	cah
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	17906000000	USD
CY2016Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4000000	shares
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19194000000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-125000000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-95000000	USD
CY2016Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	47000000	USD
CY2017Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	40000000	USD
CY2016Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	95000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	196000000	USD
CY2017Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	152000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	287000000	USD
CY2017Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6000000	shares
CY2017Q2	us-gaap	Assets Assets	40112000000	USD
CY2017Q4	us-gaap	Assets Assets	42905000000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	28345000000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	25188000000	USD
CY2017Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	USD
CY2017Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	2216000000	USD
CY2016Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	65000000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2356000000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1881000000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6879000000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1249000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-475000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5630000000	USD
CY2016Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.4489
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.8978
CY2017Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.4624
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.9248
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	364000000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	327000000	shares
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	2697000000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	2694000000	USD
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	270000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	579000000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1044000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1198000000	USD
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	270000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	580000000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1044000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1200000000	USD
CY2016Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	31548000000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	61997000000	USD
CY2017Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	33325000000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	64294000000	USD
CY2017Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	10395000000	USD
CY2017Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	9759000000	USD
CY2017Q2	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	2877000000	USD
CY2017Q4	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	3091000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	339000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	520000000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-10000000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	7000000	USD
CY2016Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.340
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.356
CY2017Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-2.319
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.366
CY2016Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8000000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	16000000	USD
CY2017Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5000000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	11000000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	32000000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1466000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1689000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	289000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	417000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	450000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	522000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	553000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3391000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5948000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1925000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4259000000	USD
	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P13Y
CY2016Q4	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-9000000	USD
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-12000000	USD
CY2017Q4	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-68000000	USD
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-68000000	USD
CY2016Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-19000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-20000000	USD
CY2017Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-58000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-90000000	USD
CY2016Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2000000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	7221000000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	10045000000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	3188000000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	23000000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	1602000000	USD
	us-gaap	Gross Profit GrossProfit	3192000000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	1861000000	USD
	us-gaap	Gross Profit GrossProfit	3533000000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	491000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	985000000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	317000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	495000000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.02
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.99
CY2017Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.35
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.70
CY2016Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	1.02
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	1.97
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	3.33
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	3.68
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	167000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	351000000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-736000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-675000000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1563000000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2107000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1294000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	995000000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	529000000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	890000000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	146000000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	617000000	USD
CY2017Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	61000000	USD
CY2017Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	62000000	USD
CY2017Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3452000000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	6010000000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1986000000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4321000000	USD
CY2017Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	9207000000	USD
CY2017Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	14366000000	USD
CY2016Q4	us-gaap	Interest Expense InterestExpense	44000000	USD
	us-gaap	Interest Expense InterestExpense	88000000	USD
CY2017Q4	us-gaap	Interest Expense InterestExpense	87000000	USD
	us-gaap	Interest Expense InterestExpense	168000000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	11301000000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	12087000000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	9068000000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	9057000000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1327000000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40112000000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42905000000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	21221000000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	23125000000	USD
CY2017Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	0	USD
CY2017Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	1339000000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	702000000	USD
CY2017Q4	us-gaap	Loss Contingency Request For Information LossContingencyRequestForInformation	39
	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	3000000	USD
	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	6000000	USD
CY2017Q2	us-gaap	Minority Interest MinorityInterest	20000000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	20000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-886000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-830000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-237000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6249000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	658000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1460000000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	324000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	633000000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	1053000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1168000000	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	542000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1076000000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	399000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	661000000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1988000000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1890000000	USD
CY2017Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2117000000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1972000000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	681000000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	804000000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	24000000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	26000000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2547000000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	29000000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	49000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-1000000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-78000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-80000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-9000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	31000000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-54000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-54000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	30000000	USD
CY2016Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000000	USD
CY2017Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	17000000	USD
	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	-14000000	USD
	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	600000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	150000000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	82000000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	293000000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	296000000	USD
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	12000000	USD
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	106000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	11000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6141000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	213000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	168000000	USD
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	3000000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	39000000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	33000000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	155000000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	324000000	USD
	us-gaap	Profit Loss ProfitLoss	634000000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	1053000000	USD
	us-gaap	Profit Loss ProfitLoss	1170000000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1879000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	60000000	USD
CY2017Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	8048000000	USD
CY2017Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	7664000000	USD
CY2017Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	118000000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	13000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	403000000	USD
CY2016Q4	us-gaap	Restructuring Charges RestructuringCharges	7000000	USD
	us-gaap	Restructuring Charges RestructuringCharges	16000000	USD
CY2017Q4	us-gaap	Restructuring Charges RestructuringCharges	21000000	USD
	us-gaap	Restructuring Charges RestructuringCharges	153000000	USD
	us-gaap	Restructuring Costs RestructuringCosts	141000000	USD
CY2017Q2	us-gaap	Restructuring Reserve RestructuringReserve	41000000	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	100000000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4967000000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5848000000	USD
CY2016Q4	us-gaap	Revenues Revenues	33150000000	USD
	us-gaap	Revenues Revenues	65189000000	USD
CY2017Q4	us-gaap	Revenues Revenues	35186000000	USD
	us-gaap	Revenues Revenues	67827000000	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	910000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1831000000	USD
CY2017Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1131000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2193000000	USD
CY2016Q4	us-gaap	Severance Costs1 SeveranceCosts1	6000000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	13000000	USD
CY2017Q4	us-gaap	Severance Costs1 SeveranceCosts1	15000000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	19000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	47000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	40000000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5000000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	59.14
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2000000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8000000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	63.44
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	64.28
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	66.44
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	6808000000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	7599000000	USD
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6828000000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7619000000	USD
CY2016Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	42000000	shares
CY2017Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	11000000	shares
	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	37000000	shares
CY2017Q2	us-gaap	Treasury Stock Value TreasuryStockValue	731000000	USD
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	848000000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	417000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	520000000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	99000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	125000000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	268000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	277000000	USD
CY2016Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1000000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000000	shares
CY2017Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1000000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	319000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	321000000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	316000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	317000000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	318000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	319000000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	315000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	315000000	shares

Files In Submission

Name	View Source	Status
0000721371-18-000020-index-headers.html	Edgar Link	pending
0000721371-18-000020-index.html	Edgar Link	pending
0000721371-18-000020.txt	Edgar Link	pending
0000721371-18-000020-xbrl.zip	Edgar Link	pending
a18q210q123117printready.pdf	Edgar Link	pending
a18q2_10qx123117xexhibit101.htm	Edgar Link	pending
a18q2_10qx123117xexhibit102.htm	Edgar Link	pending
a18q2_10qx123117xexhibit104.htm	Edgar Link	pending
a18q2_10qx123117xexhibit121.htm	Edgar Link	pending
a18q2_10qx123117xexhibit22.htm	Edgar Link	pending
a18q2_10qx123117xexhibit311.htm	Edgar Link	pending
a18q2_10qx123117xexhibit312.htm	Edgar Link	pending
a18q2_10qx123117xexhibit321.htm	Edgar Link	pending
a18q2_10qx123117xexhibit991.htm	Edgar Link	pending
a18q2_10qx123117xform10-q.htm	Edgar Link	pending
cah-20171231.xml	Edgar Link	completed
cah-20171231.xsd	Edgar Link	pending
cah-20171231_cal.xml	Edgar Link	unprocessable
cah-20171231_def.xml	Edgar Link	unprocessable
cah-20171231_lab.xml	Edgar Link	unprocessable
cah-20171231_pre.xml	Edgar Link	unprocessable
chart-385ed1d80a7e5e1c8d6.jpg	Edgar Link	pending
chart-463d175bcc285ff5ad3.jpg	Edgar Link	pending
chart-608d95ee7ddf5b47a4c.jpg	Edgar Link	pending
chart-74a06bea2909ebbbb1c.jpg	Edgar Link	pending
chart-a21c4e9da0aa523697e.jpg	Edgar Link	pending
chart-b34be478304156c0adc.jpg	Edgar Link	pending
chart-ba4c928c65b05b30894.jpg	Edgar Link	pending
chart-df485214a2c25bb2b45.jpg	Edgar Link	pending
chart-e0231ef497f45023b71.jpg	Edgar Link	pending
chart-e96c1e5390cc51cf8f7.jpg	Edgar Link	pending
chart-f7c26801ab965914b16.jpg	Edgar Link	pending
cvrpic63016a01a02a08.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CAH
CARDINAL HEALTH INC Stock $cah

2017 Q4 Form 10-Q Financial Statement

#000072137118000020 Filed on February 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH CARDINAL HEALTH INC Stock $cah

2017 Q4 Form 10-Q Financial Statement

#000072137118000020 Filed on February 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH
CARDINAL HEALTH INC Stock $cah